Colgate-Palmolive Company $CL Shares Sold by CVA Family Office LLC

CVA Family Office LLC lessened its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 7.5% in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,976 shares of the company’s stock after selling 243 shares during the quarter. CVA Family Office LLC’s holdings in Colgate-Palmolive were worth $270,000 as of its most recent filing with the SEC.

Other institutional investors also recently bought and sold shares of the company. Westend Capital Management LLC raised its stake in shares of Colgate-Palmolive by 111.1% in the 1st quarter. Westend Capital Management LLC now owns 266 shares of the company’s stock valued at $25,000 after acquiring an additional 140 shares during the period. Cornerstone Planning Group LLC boosted its position in Colgate-Palmolive by 1,913.3% during the 1st quarter. Cornerstone Planning Group LLC now owns 302 shares of the company’s stock worth $28,000 after purchasing an additional 287 shares during the period. Saudi Central Bank acquired a new stake in Colgate-Palmolive in the 1st quarter valued at $29,000. Ransom Advisory Ltd purchased a new position in Colgate-Palmolive in the first quarter valued at about $33,000. Finally, Y.D. More Investments Ltd acquired a new position in shares of Colgate-Palmolive during the first quarter worth about $37,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Performance

Colgate-Palmolive stock opened at $78.01 on Friday. Colgate-Palmolive Company has a 52 week low of $76.68 and a 52 week high of $100.18. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. The stock has a market cap of $63.05 billion, a P/E ratio of 21.91, a price-to-earnings-growth ratio of 4.58 and a beta of 0.34. The stock has a 50 day moving average of $81.33 and a 200-day moving average of $86.93.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The firm had revenue of $5.11 billion for the quarter, compared to analysts’ expectations of $5.03 billion. During the same period in the prior year, the company posted $0.91 earnings per share. The firm’s quarterly revenue was up 1.0% on a year-over-year basis. On average, analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 17th will be given a dividend of $0.52 per share. The ex-dividend date of this dividend is Friday, October 17th. This represents a $2.08 annualized dividend and a dividend yield of 2.7%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.43%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on CL shares. Weiss Ratings reiterated a “hold (c)” rating on shares of Colgate-Palmolive in a research note on Friday. Piper Sandler assumed coverage on Colgate-Palmolive in a report on Friday, October 3rd. They issued a “neutral” rating and a $84.00 price target for the company. Deutsche Bank Aktiengesellschaft set a $86.00 price objective on shares of Colgate-Palmolive in a research report on Friday, October 10th. Bank of America reduced their target price on shares of Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating on the stock in a research report on Wednesday, October 8th. Finally, Citigroup lowered their price target on shares of Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating for the company in a report on Monday, August 4th. Eight analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and an average target price of $91.50.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.